Tamil Nadu has always been in the forefront in medical care. This is also true in the field of cancer care. The predecessor of present Bernard Institute of Radiology (BIR) the Government X-ray Institute Chennai, Premier Radiological Institute and Cancer Hospital, Chennai and CMC Vellore Radiation oncology unit were all started pre independence. In the first 25 years after independence, other centres like Cancer Institute (WIA) Adyar, Chennai; Valavadi Narayanaswamy Cancer Centre Coimbatore and Government Erskines (Rajaji) Hospital, Madurai started functioning. BIR started the first diploma and degree course in radiotherapy. Asia's first cobalt therapy unit commenced function from the Cancer Institute in 1957. The country's first nuclear medicine department, medical physics department, paediatric oncology department and medical oncology department were all started in the Cancer Institute. Its founder Dr. Muthulakshmi Reddy was a great social reformer. She and her son Dr. Krishnamurthi were keen followers of Gandhiji. In the next 25 years, two new state government centres came up. The first linear accelerator in the country started functioning in the Cancer Institute. MSc (Medical Physics), MCh surgical oncology and DM medical oncology courses were stated at the Institute. Presently, there are about 100 centres functioning in the state with more than 300 qualified surgical, medical and radiation oncologists. Apollo cancer hospitals have contributed for some facilities like PET scan and proton therapy units for the first time in the country. There are about 12 hospital-based cancer registries in the state. Tamil Nadu cancer registry covers the entire 77 million population of the state. Population census-based rural free cancer screening program is conducted in four districts by the Cancer Institute. Jeevodaya is the country's second hospice facility started functioning in the suburb of Chennai from 1990 onwards. At present, there are several centres spread across the state involved in palliative care.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859956PMC
http://dx.doi.org/10.1007/s13193-022-01504-yDOI Listing

Publication Analysis

Top Keywords

cancer institute
20
cancer
13
started functioning
12
institute
9
cancer care
8
tamil nadu
8
department medical
8
medical physics
8
oncology department
8
medical oncology
8

Similar Publications

DCLRE1B as a novel prognostic biomarker associated with immune infiltration: a pancancer analysis.

Sci Rep

December 2024

Department of Orthopedics, The Second Affiliated hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi Province, China.

The DNA cross-link repair 1B (DCLRE1B) gene is involved in repairing cross-links between DNA strands, including those associated with Hoyeraal-Hreidarsson syndrome and congenital dyskeratosis. However, its role in tumours is not well understood. DCLRE1B expression profiles were examined in tumour tissues and normal tissues using TCGA, GTEx, and TARGET datasets.

View Article and Find Full Text PDF

Body composition abnormalities are prognostic markers in several types of cancer, including colorectal cancer (CRC). Using our data distribution on body composition assessments and classifications could improve clinical evaluations and support population-specific opportune interventions. This study aimed to evaluate the distribution of body composition from computed tomography and assess the associations with overall survival among patients with CRC.

View Article and Find Full Text PDF

Using Fourier Transform Infrared spectroscopy (FTIR), it is possible to show chemical composition of materials and / or profile chemical changes occurring in tissues, cells, and body fluids during onset and progression of diseases. For diagnostic application, the use of blood would be the most appropriate in biospectroscopy studies since, (i) it is easily accessible and, (ii) enables frequent analyses of biochemical changes occurring in pathological states. At present, different studies have investigated potential of serum, plasma and sputum being alternative biofluids for lung cancer detection using FTIR.

View Article and Find Full Text PDF

Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.

Sci Rep

December 2024

School of Engineering and Technology, Sunway University, No. 5, Jalan Universiti, Bandar Sunway, Petaling Jaya, 47500, Selangor Darul Ehsan, Malaysia.

Cervical cancer is a deadly disease in women globally. There is a greater chance of getting rid of cervical cancer in case of earliest diagnosis. But for some patients, there is a chance of recurrence.

View Article and Find Full Text PDF

Immune checkpoint inhibitor (ICI) treatment has proven successful for advanced melanoma, but is associated with potentially severe toxicity and high costs. Accurate biomarkers for response are lacking. The present work is the first to investigate the value of deep learning on CT imaging of metastatic lesions for predicting ICI treatment outcomes in advanced melanoma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!